Geno Pharmaceuticals Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Geno Pharmaceuticals Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $14.1M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Geno Pharmaceuticals Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $14.1M Trade | TransData Nexus

Geno Pharmaceuticals Private Limited

Indian Pharmaceutical Exporter · Cardiovascular Specialist · $14.1M Total Trade · DGFT Verified

Geno Pharmaceuticals Private Limited is an Indian pharmaceutical exporter with a total trade value of $14.1M across 2 products in 1 therapeutic categories. Based on 690 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ramipril ($14.0M), Warfarin ($90.9K), .

Geno Pharmaceuticals Private Limited — Export Portfolio & Destination Treemap

Geno Pharmaceuticals Private Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Geno Pharmaceuticals Private Limited? — Company Overview & Market Position

Geno Pharmaceuticals Private Limited, established on December 4, 1975, is a privately held pharmaceutical company headquartered in Mapusa, Goa, India. The company operates under the Corporate Identification Number (CIN) U24239GA1975PTC000250 and is registered with the Registrar of Companies, Goa. Geno Pharmaceuticals specializes in the manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. As of the latest available data, the company has an authorized capital of ₹6.50 crore and a paid-up capital of ₹3.00 crore.

The company employs approximately 1,042 professionals, reflecting its significant presence in the pharmaceutical manufacturing sector. Geno Pharmaceuticals has demonstrated consistent growth, with a 7.5% increase in total revenue for the financial year ending March 31, 2023. However, profitability experienced a slight decline, with a 9.25% decrease in net profit during the same period.

What Does Geno Pharmaceuticals Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Ramipril$14.0M 2

Product Portfolio — Top 2 by Export Value

Geno Pharmaceuticals Private Limited exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Ramipril	Cardiovascular	$14.0M	686	15.6%	2
2	Warfarin	Cardiovascular	$90.9K	4	1.2%	10

Geno Pharmaceuticals Private Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $14.1M. The top category is Cardiovascular (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Geno Pharmaceuticals Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Geno Pharmaceuticals operates its manufacturing facilities at the Tivim Industrial Estate in Mapusa, Goa. The plant is equipped to produce a diverse range of pharmaceutical dosage forms, including tablets, capsules, syrups, and injections. The facility has been upgraded to meet international quality standards, obtaining certifications such as WHO-GMP and EU-GMP, which underscores its commitment to maintaining high manufacturing standards.

3Key Leadership

The leadership team at Geno Pharmaceuticals is headed by Managing Director Dr. Sagar D. Salgaocar, who holds an MBBS and MS in Orthopaedics. Dr. Salgaocar has been instrumental in the company's growth, particularly in enhancing its manufacturing capabilities to meet international standards. Other key executives include Mrs. Pallavi Sagar Salgaocar, Whole-Time Director, and Mr. Dilip R. Salgaocar, Director. The leadership team also comprises directors such as Mr. Shivam Sagar Salgaocar, Mrs. Teja Mahesh Gadekar, and Mr. Suriakiran Umacanta Sinaikunde.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Geno Pharmaceuticals Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Geno Pharmaceuticals has made significant strides in accessing regulated markets, particularly in the European Union. The company received EU-GMP certification in 2018, enabling it to export pharmaceutical products to EU member countries. This certification reflects the company's adherence to stringent manufacturing practices required by European regulators. While specific details regarding approvals in the United States, United Kingdom, Australia, and Japan are not publicly available, the EU-GMP certification positions Geno Pharmaceuticals favorably for potential market entry into these regions.

2Emerging Markets

Geno Pharmaceuticals has expanded its presence in emerging markets, including Africa, Latin America, and Southeast Asia. The WHO-GMP certification obtained in 1998 has facilitated access to these markets by ensuring compliance with international quality standards. This certification has been instrumental in establishing trust and credibility among healthcare providers and regulatory authorities in these regions.

3Geographic Strategy

Geno Pharmaceuticals has strategically diversified its market presence by obtaining certifications such as WHO-GMP and EU-GMP, enabling access to both regulated and emerging markets. This approach mitigates concentration risk and positions the company to leverage growth opportunities across different regions. The focus on international certifications underscores the company's commitment to quality and its strategic direction toward global expansion.

Geno Pharmaceuticals Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Geno Pharmaceuticals' interactions with the U.S. Food and Drug Administration (FDA), including facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history, are not publicly available. The absence of publicly accessible information suggests that the company may not currently have FDA approvals or may not have pursued market entry into the U.S. at this time.

2WHO & EU GMP

Geno Pharmaceuticals has achieved WHO-GMP certification in 1998 and EU-GMP certification in 2018. These certifications validate the company's adherence to international manufacturing standards, enhancing its credibility and facilitating access to global markets. The EU-GMP certification, in particular, has been pivotal in enabling the company to export products to European Union member countries.

3CDSCO & Indian Regulatory

Geno Pharmaceuticals holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority in India. The company has also obtained necessary approvals from state drug controllers and export No Objection Certificates (NOCs), ensuring compliance with Indian regulatory requirements for domestic and international operations.

Geno Pharmaceuticals Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Geno Pharmaceuticals operates in a competitive landscape with several key players in the Indian pharmaceutical manufacturing sector. While specific market share data is not publicly available, the company's WHO-GMP and EU-GMP certifications position it favorably in the market. The focus on quality manufacturing and adherence to international standards differentiates Geno Pharmaceuticals from competitors.

2Key Differentiators

Geno Pharmaceuticals' key differentiators include its long-standing presence in the industry since 1975, a diverse product portfolio encompassing tablets, capsules, syrups, and injections, and a strong commitment to quality evidenced by WHO-GMP and EU-GMP certifications. These factors contribute to the company's competitive advantage in both domestic and international markets.

3Strategic Position

Geno Pharmaceuticals' strategic direction focuses on expanding its presence in regulated markets through certifications like WHO-GMP and EU-GMP. The company's future outlook includes leveraging these certifications to enter new markets and strengthen its position in existing ones. The emphasis on quality manufacturing and compliance with international standards supports this strategic direction.

Buyer Due Diligence Brief — Evaluating Geno Pharmaceuticals Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Geno Pharmaceuticals has demonstrated a consistent track record in pharmaceutical manufacturing, with a history of obtaining international certifications and maintaining compliance with regulatory standards. The company's export volume and consistency are supported by its adherence to WHO-GMP and EU-GMP standards, indicating reliability in meeting international quality expectations.

2Certifications to Verify

Importers should verify the following certifications when considering Geno Pharmaceuticals as a supplier:

WHO-GMP Certification: Confirms compliance with World Health Organization Good Manufacturing Practices. Verification can be done through the WHO official website or by contacting the company directly.

EU-GMP Certification: Indicates adherence to European Union Good Manufacturing Practices. Verification can be conducted through the European Medicines Agency (EMA) or by reaching out to the company.

Frequently Asked Questions — Geno Pharmaceuticals Private Limited

How many pharmaceutical products does Geno Pharmaceuticals Private Limited export from India?

Geno Pharmaceuticals Private Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Ramipril ($14.0M), Warfarin ($90.9K). Total export value is $14.1M.

What is Geno Pharmaceuticals Private Limited's total pharmaceutical export value?

Geno Pharmaceuticals Private Limited's total pharmaceutical export value is $14.1M, based on 690 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Geno Pharmaceuticals Private Limited cover?

Geno Pharmaceuticals Private Limited exports across 1 therapeutic categories. The largest are Cardiovascular (100.0%, 2 products).

Get Full Geno Pharmaceuticals Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.